Microdevice for Evaluating Drug Response in Site in Lung Lesions

NCT03972228 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Lung Tumor
Lung Cancer

Interventions

COMBINATION_PRODUCT: Microdevice loaded with 19 chemotherapeutic agents

Sponsor

Oliver Jonas

Collaborators

[object Object]